The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Lednev P.V.

Otdelenie kardiokhirurgii kliniki aortal'noĭ i serdechno-sosudistoĭ khirurgii Pervogo MGMU im. I.M. Sechenova

Stonogin A.V.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

Lysenko A.V.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

Nikityuk T.G.

Acad. B.V. Petrovsky Russian Scientific Surgery Center, Moscow, Russia

Salagaev G.I.

Chair of Cardiovascular Surgery and Interventional Cardiology, I.M. Sechenov First Moscow State Medical University (head — MD R.N. Komarov), acad. B.V. Petrovsky Russian Research Center for Surgery (director — acad. of RAS Yu.V. Belov), Moscow, Russia

Belov Yu.V.

RNTsKh im. akad. B.V. Petrovskogo RAMN

Conservative treatment of thrombosis of aortic valve bioprosthesis

Authors:

Lednev P.V., Stonogin A.V., Lysenko A.V., Nikityuk T.G., Salagaev G.I., Belov Yu.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2018;(12): 129‑131

Read: 1991 times


To cite this article:

Lednev PV, Stonogin AV, Lysenko AV, Nikityuk TG, Salagaev GI, Belov YuV. Conservative treatment of thrombosis of aortic valve bioprosthesis. Pirogov Russian Journal of Surgery. 2018;(12):129‑131. (In Russ.)
https://doi.org/10.17116/hirurgia2018121129

References:

  1. Brown ML, Park SJ, Sundt TM, Schaff HV. Early thrombosis risk in patients with biologic valves in the aortic position. J Thorac Cardiovasc Surg. 2012;144(1):108-111. https://doi.org/10.1016/j.jtcvs.2011.05.032
  2. Puvimanasinghe JP, Steyerberg EW, Takkenberg JJ, Eijkemans MJ, van Herwerden LA, Bogers AJ, et al. Prognosis after aortic valve replacement with a bioprosthesis: predictions based on metaanalysis and microsimulation. Circulation. 2001;103(11):1535-1541.
  3. Butnaru A, Shaheen J, Tzivoni D, Tauber R, Bitran D, Silberman S. Diagnosis and treatment of early bioprosthetic malfunction in the mitral valve position due to thrombus formation. Am J Cardiol. 2013;112(9):1439-1444. https://doi.org/10.1016/j.amjcard.2013.06.014
  4. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2017;135(25):e1159-e1195. https://doi.org/10.1161/CIR.0000000000000503
  5. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739-2791. https://doi.org/10.1093/eurheartj/ehx391
  6. Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, De Backer O, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373(21):2015-2024. https://doi.org/10.1056/NEJMoa1509233
  7. Sundt TM, Zehr KJ, Dearani JA, Daly RC, Mullany CJ, McGregor CGA, et al. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? J Thorac Cardiovasc Surg. 2005;129(5):1024-1031. https://doi.org/10.1016/j.jtcvs.2004.11.028
  8. McClure RS, McGurk S, Cevasco M, Maloney A, Gosev I, Wiegerinck EM, et al. Late outcomes comparison of nonelderly patients with stented bioprosthetic and mechanical valves in the aortic position: a propensity-matched analysis. J Thorac Cardiovasc Surg. 2014;148(5):1931-1939. https://doi.org/10.1016/j.jtcvs.2013.12.042

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.